Multicentre study on resection margins in carcinoma of the oral cavity, oro-hypopharynx and larynx.


Journal

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
ISSN: 1827-675X
Titre abrégé: Acta Otorhinolaryngol Ital
Pays: Italy
ID NLM: 8213019

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 04 04 2021
accepted: 27 10 2021
entrez: 25 5 2022
pubmed: 26 5 2022
medline: 28 5 2022
Statut: ppublish

Résumé

The prognostic significance of the resection margins is still subject of conflicting opinions. The purpose of this paper is to report the results of a study on the margins in carcinoma of the oral cavity, oro-hypopharynx and larynx. A multicentre prospective study was carried out between 2015 and 2018 with the participation of 10 Italian reference hospitals. The primary objective was to evaluate local control in patients with well-defined clinical characteristics and comprehensive histopathological information. During the study period, 455 patients were enrolled; the minimum follow-up was 2 years. Previous treatment, grading and fresh specimen examination were identified as risk factors for local control in multivariate analysis. On the basis of these results, it seems possible to delineate "risk profiles" for different oncological outcomes. The prognostic significance of the margins is reduced, and other risk factors emerge, which require diversified treatment and follow-up. Multidisciplinary treatment with adjuvant therapy, if indicated, reduces the prognostic importance of margins. Collaboration with a pathologist is an additional favourable prognostic factor and quality indicator. An appendix with literature review is present in the online version. Studio multicentrico sui margini di resezione nel carcinoma del cavo orale, faringe e laringe. Il significato prognostico dei margini di resezione è ancora oggetto di pareri discordanti. Scopo di questo scritto è riportare i risultati di uno studio sui margini nel carcinoma del cavo orale, oro-ipofaringe e laringe. È stato condotto uno studio prospettico multicentrico con la partecipazione di 10 Centri italiani, nel periodo 2015-2018, con l’obiettivo primario di valutare il controllo locale in pazienti con ben determinate caratteristiche cliniche e con disponibilità di esaurienti informazioni istopatologiche. Nel periodo in studio sono stati arruolati 455 pazienti con un follow-up minimo di 2 anni. All’analisi multivariata per il controllo locale sono risultati fattori di rischio il trattamento precedente, il grading e l’esame a fresco dello specimen. Sulla base dei risultati ottenuti è possibile delineare un “profilo di rischio” per tutti i diversi outcomes oncologici. Il significato prognostico dei margini è ridotto, altri fattori emergono come profili di rischio, che richiederebbero trattamento e follow-up diversificati. Il trattamento multidisciplinare con la terapia adiuvante se indicata, può aver ridimensionato l’importanza prognostica dei margini. La collaborazione con l’anatomopatologo è fattore prognostico favorevole supplementare ed indicatore di qualità. Appendice con revisione della letteratura nella versione online.

Autres résumés

Type: Publisher (ita)
Studio multicentrico sui margini di resezione nel carcinoma del cavo orale, faringe e laringe.

Identifiants

pubmed: 35612504
doi: 10.14639/0392-100X-N1601
pmc: PMC9132003
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-139

Informations de copyright

Copyright © 2022 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy.

Références

Head Neck. 2018 Jun;40(6):1228-1236
pubmed: 29417700
JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1043-1051
pubmed: 26402479
Oral Oncol. 2020 Dec;111:104938
pubmed: 32739791
Head Neck. 2008 Jul;30(7):845-51
pubmed: 18302256
Head Neck. 2016 Jan;38(1):59-65
pubmed: 25197014
Oral Oncol. 2020 Dec;111:105004
pubmed: 33038750
Head Neck. 2016 Apr;38 Suppl 1:E2197-203
pubmed: 25899524
Head Neck. 2014 Jun;36(6):811-8
pubmed: 23696499
Oral Oncol. 2020 Nov;110:104883
pubmed: 32659737
Laryngoscope. 2015 Oct;125(10):2298-307
pubmed: 26011037
Head Neck. 2013 Sep;35(9):1362-70
pubmed: 22941934
Am J Surg Pathol. 2005 Feb;29(2):167-78
pubmed: 15644773
Head Neck. 2005 Oct;27(10):843-50
pubmed: 16161069
JAMA Otolaryngol Head Neck Surg. 2015 Jul;141(7):593-8
pubmed: 25974757
Cancer. 2013 Jul 1;119(13):2427-37
pubmed: 23576156
Oral Oncol. 2007 Apr;43(4):321-6
pubmed: 17112772
Oral Oncol. 2015 May;51(5):464-9
pubmed: 25716108
Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2603-9
pubmed: 23271033
JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1166-1172
pubmed: 28445581
Oral Oncol. 2014 Jun;50(6):611-5
pubmed: 24630900
Clin Otolaryngol. 2019 Jan;44(1):63-69
pubmed: 30296003
Curr Probl Cancer. 2019 Dec;43(6):100500
pubmed: 31481249
Am J Otolaryngol. 1998 Jan-Feb;19(1):24-8
pubmed: 9470947

Auteurs

Luigi Barzan (L)

prev. Head & Neck Surgery, Oncology Referral Center-CRO, Aviano, Pordenone, Italy.

Cristina Montomoli (C)

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Italy.

Roberto Di Carlo (R)

ENT Clinic, University of Padua, Italy.

Martina Bertinazzi (M)

ENT Clinic, University of Padua, Italy.

Roberta Colangeli (R)

ENT Clinic, University of Padua, Italy.

Alessandro Martini (A)

ENT Clinic, University of Padua, Italy.

Piero Nicolai (P)

ENT Clinic, University of Padua, Italy.

Elena Gaio (E)

ENT Department, Hospital of Cittadella, Padua, Italy.

Riccardo Artico (R)

ENT Department, Hospital of Cittadella, Padua, Italy.

Valentina Lupato (V)

ENT Dept, Hospital of Pordenone, Italy.

Vittorio Giacomarra (V)

ENT Dept, Hospital of Pordenone, Italy.

Francesca Boscolo Nata (F)

ENT Clinic, University of Trieste, Italy.

Giancarlo Tirelli (G)

ENT Clinic, University of Trieste, Italy.

Lucia Lora (L)

ENT Department, Hospital of Mestre-Venice, Italy.

Doriano Politi (D)

ENT Department, Hospital of Mestre-Venice, Italy.

Roberto Spinato (R)

ENT Department, Hospital of Mestre-Venice, Italy.

Anna Menegaldo (A)

ENT Department, University of Treviso-Padua, Italy.

Paolo Boscolo Rizzo (P)

ENT Department, University of Treviso-Padua, Italy.

Maria Cristina Da Mosto (MC)

ENT Department, University of Treviso-Padua, Italy.

Francesco Fiorino (F)

ENT Department, Hospital of Legnago, Verona, Italy.

Irene Herman (I)

ENT Clinic, University of Pavia, Italy.

Marco Benazzo (M)

ENT Clinic, University of Pavia, Italy.

Alessandro La Boria (A)

ENT Department, Hospital of Trento, Italy.

Cesare Grandi (C)

ENT Department, Hospital of Trento, Italy.

Giuseppe Fanetti (G)

Radiotherapy Unit, CRO Aviano, Pordenone, Italy.

Gianni Franchin (G)

Radiotherapy Unit, CRO Aviano, Pordenone, Italy.

Vincenzo Canzonieri (V)

Unit of Pathology, CRO Aviano, Pordenone, Italy.

Sandro Sulfaro (S)

Unit of Pathology, Hospital of Pordenone, Italy.

Guido Mazzoleni (G)

Unit of Pathology, Hospital of Bolzano.

Emanuela Vaccher (E)

Department of Medical Oncology, CRO Aviano, Pordenone, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH